These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 37236195)

  • 1. Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity.
    Liu X; Hogg GD; Zuo C; Borcherding NC; Baer JM; Lander VE; Kang LI; Knolhoff BL; Ahmad F; Osterhout RE; Galkin AV; Bruey JM; Carter LL; Mpoy C; Vij KR; Fields RC; Schwarz JK; Park H; Gupta V; DeNardo DG
    Cancer Cell; 2023 Jun; 41(6):1073-1090.e12. PubMed ID: 37236195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors.
    DeNardo DG; Galkin A; Dupont J; Zhou L; Bendell J
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-κB activation enhances STING signaling by altering microtubule-mediated STING trafficking.
    Zhang L; Wei X; Wang Z; Liu P; Hou Y; Xu Y; Su H; Koci MD; Yin H; Zhang C
    Cell Rep; 2023 Mar; 42(3):112185. PubMed ID: 36857187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
    Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.
    Lin L; Wu C; Hu K
    J Am Soc Nephrol; 2012 Aug; 23(8):1329-38. PubMed ID: 22677557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy.
    Li Y; Yi J; Ma R; Wang Y; Lou X; Dong Y; Cao Y; Li X; Wang M; Dang X; Li R; Lei N; Song H; Qin Z; Yang W
    J Control Release; 2024 Sep; 373():447-462. PubMed ID: 39038546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies.
    Panni RZ; Herndon JM; Zuo C; Hegde S; Hogg GD; Knolhoff BL; Breden MA; Li X; Krisnawan VE; Khan SQ; Schwarz JK; Rogers BE; Fields RC; Hawkins WG; Gupta V; DeNardo DG
    Sci Transl Med; 2019 Jul; 11(499):. PubMed ID: 31270275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC.
    Zhu G; Tang Y; Geng N; Zheng M; Jiang J; Li L; Li K; Lei Z; Chen W; Fan Y; Ma X; Li L; Wang X; Liang X
    Neoplasia; 2014 Feb; 16(2):168-79. PubMed ID: 24709424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TBK1 recruitment to STING activates both IRF3 and NF-κB that mediate immune defense against tumors and viral infections.
    Yum S; Li M; Fang Y; Chen ZJ
    Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33785602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1.
    Abe T; Barber GN
    J Virol; 2014 May; 88(10):5328-41. PubMed ID: 24600004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of micronucleus-activated cGAS-STING signaling in antitumor immunity.
    Shen Q; Xu P; Mei C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 53(1):25-34. PubMed ID: 38273467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Allosteric Modulation of CD11b as a Novel Therapeutic Strategy Against Lung Cancer.
    Geraghty T; Rajagopalan A; Aslam R; Pohlman A; Venkatesh I; Zloza A; Cimbaluk D; DeNardo DG; Gupta V
    Front Oncol; 2020; 10():748. PubMed ID: 32528880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 14. 15-hydroxy-6
    Zhao Q; Lu L; Du G; Wang Z; Li X; Ju F
    Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):358-365. PubMed ID: 32508184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells.
    Balka KR; Louis C; Saunders TL; Smith AM; Calleja DJ; D'Silva DB; Moghaddas F; Tailler M; Lawlor KE; Zhan Y; Burns CJ; Wicks IP; Miner JJ; Kile BT; Masters SL; De Nardo D
    Cell Rep; 2020 Apr; 31(1):107492. PubMed ID: 32268090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
    Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between the SFTSV envelope glycoprotein Gn and STING inhibits the formation of the STING-TBK1 complex and suppresses the NF-κB signaling pathway.
    Jia Y; Li F; Liu Z; Liu S; Huang M; Gao X; Su X; Wang Z; Wang T
    J Virol; 2024 Mar; 98(3):e0181523. PubMed ID: 38421179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy.
    Medvedeva GF; Kuzmina DO; Nuzhina J; Shtil AA; Dukhinova MS
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB: Governing Macrophages in Cancer.
    Cornice J; Verzella D; Arboretto P; Vecchiotti D; Capece D; Zazzeroni F; Franzoso G
    Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA.
    Kim J; Pena JV; McQueen HP; Kong L; Michael D; Lomashvili EM; Cook PR
    Cancer Gene Ther; 2024 Jan; 31(1):28-42. PubMed ID: 37990062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.